Coherus BioSciences Inc.

NASDAQ: CHRS · Real-Time Price · USD
1.04
0.02 (1.96%)
At close: Aug 15, 2025, 3:59 PM
1.02
-2.39%
After-hours: Aug 15, 2025, 07:33 PM EDT

Coherus BioSciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
10.25M 7.6M 54.14M 70.77M 64.98M 2.31M 91.52M 74.57M 58.72M 32.44M 45.35M 45.42M 60.15M 60.12M 73.37M 82.5M 87.64M 83.03M
Cost of Revenue
4.41M 2.65M 33.86M 20.74M 29.55M 36.09M 85.63M 32.7M 24.85M 16.87M 14.2M 35.23M 11.28M 9.37M 12.1M 21.28M 16.7M 7.51M
Gross Profit
5.84M 4.95M 20.29M 50.03M 35.42M 40.97M 5.89M 41.87M 33.87M 15.56M 31.15M 10.19M 48.87M 50.74M 61.27M 61.22M 70.95M 75.52M
Operating Income
-45.49M -45.44M -42.25M -6.39M -20.51M -42.52M -68.36M -32.01M -34.54M -67.75M -51.49M -80.45M -44.01M -80.92M -39.55M -32.79M -24.16M -167.36M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-44.86M -47.4M -50.7M -10.75M -12.92M 102.88M -79.65M -40.02M -42.87M -75.73M -58.87M -86.65M -50.15M -96.08M -45.73M -38.53M -29.9M -172.95M
Net Income
297.77M -56.57M -50.7M -10.75M -12.92M 102.88M -79.65M -39.64M -42.87M -74.78M -66.25M -92.85M -56.29M -111.24M -45.73M -38.53M -29.9M -172.95M
Selling & General & Admin
26.04M 26.02M 41.3M 34.74M 35.16M 49.73M 48.95M 48.22M 45.14M 49.15M 53.62M 44.83M 51.28M 48.75M 50.05M 39.92M 40.34M 39.39M
Research & Development
26.31M 24.36M 21.23M 21.68M 20.77M 26.96M 25.3M 25.65M 23.27M 34.15M 29.02M 45.81M 41.61M 82.92M 50.76M 54.09M 54.77M 203.49M
Other Expenses
-1.02M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 443K 32K -385K 30K 11K 61K
Operating Expenses
51.33M 50.38M 62.53M 56.42M 55.93M 76.69M 74.25M 73.87M 68.41M 83.31M 82.64M 90.64M 92.89M 131.67M 100.81M 94.01M 95.11M 242.88M
Interest Expense
2.28M 2.15M 5.35M 5.36M 5.33M 11.12M 10.62M 10.27M 9.94M 9.71M 9.38M 7.54M 6.58M 8.97M 5.79M 5.77M 5.75M 5.65M
Selling & Marketing Expenses
n/a n/a 10.9M n/a n/a n/a 10.9M n/a n/a n/a 10.5M n/a n/a n/a 8.7M n/a n/a n/a
Cost & Expenses
55.74M 53.03M 96.39M 77.16M 85.49M 70.09M 159.88M 106.57M 93.26M 100.18M 96.84M 125.87M 104.16M 141.04M 112.92M 115.29M 111.81M 250.39M
Income Tax Expense
-342.63M n/a n/a n/a n/a n/a n/a -380K n/a -949K 7.38M 6.2M 6.14M 15.16M n/a n/a n/a n/a
Shares Outstanding (Basic)
116.08M 115.86M 115.42M 115.21M 114.82M 112.75M 111.49M 97.74M 87.27M 79.27M 77.96M 77.75M 77.15M 77.25M 76.35M 78.63M 75.56M 72.83M
Shares Outstanding (Diluted)
116.08M 115.86M 115.42M 115.21M 114.82M 125.53M 111.49M 97.74M 87.27M 79.27M 77.96M 77.75M 77.55M 77.25M 76.83M 79.01M 75.56M 72.83M
EPS (Basic)
-0.36 -0.49 -0.44 -0.09 -0.11 0.91 -0.71 -0.41 -0.49 -0.94 -0.85 -1.19 -0.73 -1.44 -0.6 -0.49 -0.4 -2.37
EPS (Diluted)
-0.36 -0.49 -0.44 -0.09 -0.11 0.82 -0.71 -0.41 -0.49 -0.94 -0.85 -1.19 -0.73 -1.44 -0.6 -0.49 -0.4 -2.37
EBITDA
-45.49M -44.2M -44.32M -3.84M -6.4M 115.5M -67.97M -28.12M -32.05M -65.07M -48.44M -78.21M -42.67M -86.35M -38.51M -31.3M -23.28M -165.92M
EBIT
-42.59M -45.25M -45.35M -5.39M -7.59M 113.99M -69.03M -29.75M -32.93M -66.02M -49.48M -79.11M -43.57M -87.11M -39.93M -32.76M -24.15M -167.3M
Depreciation & Amortization
1.02M 1.05M 1.03M 1.55M 1.19M 1.51M 1.06M 1.64M 880K 949K 1.05M 900K 900K 767K 1.43M 1.45M 1.44M 1.38M